WBTP is first program to offer novel non-chemo therapy in WestchesterFebruary 4th, 2013 | Posted by in News
The Westchester Brain Tumor Program is now offering Tumor Transfer Fields (TTFields) therapy, a non-invasive alternative to chemotherapy for patients with recurrent glioblastoma multiforme. TTFields therapy uses alternating electrical fields to slow and reverse tumor growth by disrupting the uncontrolled division of cancer cells. WBTP is using the NovoTTF (TM) system from Novocure.
Similar benefits to chemo, fewer side effects
“This novel, non-invasive therapy has the same life-extending benefits of chemotherapy but with the added benefit of fewer side effects and a much, much better quality of life,” explains John Abrahams, M.D., founder and director of the Westchester Brain Tumor Program and Chief of Neurosurgery at Northern Westchester Hospital.
The therapy is delivered via four non-invasive, insulated transducer arrays that are placed directly on the scalp and worn continuously. Patients carry a portable power source so they can continue their everyday activities.
Dr. Abrahams points to a study published this fall in the European Journal of Cancer that found patients treated with TTFields reported less fatigue, pain, infections, and GI disorders than patients treated with chemotherapy. “TTFields is a welcomed addition to our treatment modalities,” Dr. Abrahams says. “More options translates into better care for our patients.”